WuXi AppTec (603259.SH): 3Q26 earnings call takeaways: Geopolitics risk lower as growth visibility strengthens; raising PT

WuXi AppTec's 3Q26 results reinforce the growth outlook, with revenue up 38% YoY to Rmb16.64bn and adjusted net profit up 61% to Rmb6.81bn. Continuing-operations revenue grew 43.5% YoY, supporting another FY26 guidance upgrade. Our key takeaway from the call is improving revenue visibility as projects advance into late-stage development and commercial production. Strong bookings support growth into 2027, while AI drug discovery (AIDD) customers offer additional laboratory demand. Capacity expansion should support delivery, but overseas ramp-up costs and potential US policy risk remain key watchpoints. On geopolitical risks, the company noted that it has not received notice from the U.S. OMB that it could be put on the BCC list; a quick channel check suggests no major Chinese CXOs have received such notice. With the strong 3Q26 print, we have raised our PTs by ~5% to Rmb210/HK$233 for WuXi AppTec A/H shares. WuXi AppTec remains one of our top picks in the China CXO space.